MedTrace Logo

Impact of Moderate Exercise Training on Vitals and Peak VO2 in Different Age Categories of Adult in COVID-19.

NCT04927182 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2021-10-20

No results posted yet for this study

Summary

* To determine the impact of moderate exercise training on vitals (BP, HR) in different age categories of adult in COVID-19.
* To determine the Impact of moderate exercise training on Peak VO2 in different age categories of adult in COVID-19
* To determine muscle discomfort due to physical training.

Conditions

  • Covid19

Interventions

OTHER

Moderate Exercise Training (Age Group 1; Young adult 17 -30 years)

Supervised Moderate exercise training will be given. This protocol consisted of 3 types of exercises. This includes walking/jogging/running for 23 minutes cycling for 23 minutes and stepping for 5 minutes. The protocol will be performed in 50 minutes sessions thrice a week.

OTHER

Moderate Exercise Training (Age Group 2; 31 to 45 years)

Supervised Moderate exercise training will be given. This protocol consisted of 3 types of exercises. This includes walking/jogging/running for 23 minutes cycling for 23 minutes and stepping for 5 minutes. The protocol will be performed in 50 minutes sessions thrice a week.

OTHER

Moderate Exercise Training (Age Group 3; Above 45 years)

Supervised Moderate exercise training will be given. This protocol consisted of 3 types of exercises. This includes walking/jogging/running for 23 minutes cycling for 23 minutes and stepping for 5 minutes. The protocol will be performed in 50 minutes sessions thrice a week.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Muhammad Iqbal Tariq, MSCPPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04927182 on ClinicalTrials.gov